The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent von Grasselly, Chloé, Denis, Morgane, Bourguignon, Aurore, Talhi, Nolan, Mathe, Doriane, Tourette, Anne, Serre, Laurent, Jordheim, Lars Petter, Matera, Eva Laure, Dumontet, Charles

Volltext

Abstract 2723: In vivo activity of combinations of cytotoxic regimens with anti-PD1 and anti-PDL1 in various syngeneic cancer models von Grasselly, Chloé, Denis, Morgane, Bourguignon, Aurore, Talhi, Nolan, Tourette, Anne, Mathe, Doriane, Serre, Laurent, Jordheim, Lars Petter, Dumontet, Charles

Volltext

IN VIVO SYNGENEIC TUMOR MODELS WITH ACQUIRED RESISTANCE TO ANTI-PD-1/PD-L1 THERAPIES von Denis, Morgane, Grasselly, Chloé, Choffour, Pierre-Antoine, Wierinckx, Anne, Mathe, Doriane, Chettab, Kamel, Tourette, Anne, Talhi, Nolan, Bourguignon, Aurore, Birzele, Fabian, Kress, Elsa, Jordheim, Lars Petter, Klein, Christian, Matera, Eva Laure, Dumontet, Charles

Volltext

Abstract 4200: Characterization of acquired resistant models to therapies targeting the PD-1/PD-L1 axis demonstrates model-dependent mechanisms von Denis, Morgane, Grasselly, Chloé, Choffour, Pierre-Antoine, Wierinckx, Anne, Mathé, Doriane, Chettab, Kamel, Tourette, Anne, Talhi, Nolan, Birzele, Fabian, Kress, Elsa, Jordheim, Lars Petter, Klein, Christian, Matera, Eva-Laure, Dumontet, Charles

Volltext